Related Experiment Video
Updated: Feb 17, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
Published on: March 7, 2017
Paediatric Peripheral Primitive Neuroectodermal Tumour - A Clinico-Pathological Study from Southern India
Rithika Rajendran1, Leena Dennis Joseph2, Thanka Johnson2
1Phd Scholar, Department of Pathology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Chennai, Tamil Nadu, India.
Metastasis at diagnosis significantly impacts prognosis for pediatric Primitive Neuroectodermal Tumors (PNET)/Ewing Sarcomas (ES). Early detection and multidisciplinary care improve survival rates for localized disease.
Area of Science:
- Pediatric Oncology
- Skeletal Muscle Tumors
- Pediatric Pathology
Background:
- Primitive Neuroectodermal Tumors (PNET) and Ewing Sarcomas (ES) are aggressive childhood cancers.
- These malignancies exhibit neuroectodermal differentiation.
Purpose of the Study:
- To analyze the clinical presentation, morphology, immunohistochemistry (IHC), management, and outcomes of pediatric PNET/ES.
- To evaluate factors influencing survival in this patient cohort.
Main Methods:
- Retrospective study of biopsy-proven pediatric PNET/ES cases (<18 years) over six years.
- Clinical data, treatment, and follow-up were retrieved and analyzed.
- Survival rates were calculated, and Kaplan-Meier curves were generated.
Main Results:
- Eleven cases of pediatric peripheral PNET/ES were identified.
- The mean age at presentation was 94.08 months; male/female ratio was 1.2:1.
- 81.8% survival rate observed; metastasis at diagnosis was associated with significantly shorter survival (9.66 months vs. 25 months for localized disease).
Conclusions:
- Metastasis at diagnosis is the primary determinant of poor prognosis in pediatric PNET/ES.
- Immunohistochemistry (IHC) is crucial for accurate diagnosis of these small round blue cell tumors.
- Multidisciplinary management and supportive care enhance survival for localized disease.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
07:44Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025